MYH9 and neuroblastoma: Piskareva et al. found that elevated MYH9 levels induce EMT in neuroblastoma cells (Piskareva et al., 2015), a crucial feature in the development of cisplatin resistance in neuroblastoma (Xu et al., 2020; Belhajova et al., 2022; Li H. et al., 2022).